Spinocerebellar ataxias (SCAs) represent a genetically heterogeneous subset of autosomal dominant progressive neurological disorders predominantly caused by expansion of a glutamine-encoding CAG trinucleotide repeat, leading to the accumulation of misfolded proteins, dysfunction of ion channels and mitochondria, and ultimately neurodegeneration, with PCs, brainstem, and spinal cord neurons being particularly affected in SCA type 1 (Watase et al., 2002
Moreover, rodent models are often exposed to UV light at much higher doses than diurnal animals experience environmentally in order to shorten the experimental time course required for the development of cataract
Genes Dev 12:557570 Moreira S, Stramer B, Evans I, Wood W, Martin P (2010) Prioritization of competing damage and developmental signals by migrating macrophages in the Drosophila embryo
(34457354) The use of steroids in fat embolism syndrome is controversial, with some evidence suggesting that steroids reduce the incidence of hypoxemia
Certificate of Analysis Cagrilintide 10mg COA Number 2606240314 Lot PH-ca10-0126 Reported 06/27/2026 Certificate of Analysis Cagrilintide 5mg COA Number 2605280419 Lot PH-ca51021 Reported 05/30/2026 Certificate of Analysis Cagrilintide 10mg COA Number 2604300059 Lot PH-CA10-0126 Reported 05/01/2026 Certificate of Analysis Cagrilintide 5mg COA Number 2603020050 Lot PH-CAG050803 Reported 03/02/2026 Cagrilintide Peptide Specifications Cagrilintide Chemical Structure Legal Disclaimer: Cagrilintide is sold by Protide Health for laboratory research purposes only